Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01485
|
|||||
| Drug Name |
Leukotriene E4
|
|||||
| Synonyms |
Leukotriene E4; leukotriene E4; Leukotriene E; UNII-8EYT8ATL7G; 75715-89-8; 8EYT8ATL7G; CHEMBL509456; CHEBI:15650; OTZRAYGBFWZKMX-FRFVZSDQSA-N; 5S-hydroxy,6R-(S-cysteinyl),7E,9E,11Z,14Z-eicosatetraenoic acid; C23H37NO5S; (5S-(5R*,6S*(S*),7E,9E,11Z,14Z))-6-((2-Amino-2-carboxyethyl)thio)-5-hydroxy-7,9,11,14-eicosatetraenoic acid; (5S,6R,7E,9E,11Z,14Z)-6-[(2R)-2-amino-3-hydroxy-3-oxopropyl]sulfanyl-5-hydroxyicosa-7,9,11,14-tetraenoic acid; [3H]LTE4; AC1NQXPM; LEUKOTRIEN E4; BSPBio_001370; leukotriene E
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Asthma [ICD11: CA23] | Preclinical | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C23H37NO5S
|
|||||
| Canonical SMILES |
CCCCCC=CCC=CC=CC=CC(C(CCCC(=O)O)O)SCC(C(=O)O)N
|
|||||
| InChI |
InChI=1S/C23H37NO5S/c1-2-3-4-5-6-7-8-9-10-11-12-13-16-21(30-18-19(24)23(28)29)20(25)15-14-17-22(26)27/h6-7,9-13,16,19-21,25H,2-5,8,14-15,17-18,24H2,1H3,(H,26,27)(H,28,29)/b7-6-,10-9-,12-11+,16-13+/t19-,20-,21+/m0/s1
|
|||||
| InChIKey |
OTZRAYGBFWZKMX-FRFVZSDQSA-N
|
|||||
| CAS Number |
CAS 75715-89-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 439.6 | Topological Polar Surface Area | 146 | ||
| Heavy Atom Count | 30 | Rotatable Bond Count | 18 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 7 | |||
| XLogP |
2.1
|
|||||
| PubChem CID | ||||||
| PubChem SID |
8236
, 4266070
, 7979753
, 8143276
, 8616419
, 16344702
, 26756770
, 39289868
, 48409442
, 50111414
, 57357904
, 74701367
, 96099805
, 103591347
, 104138918
, 113854149
, 127316814
, 127316815
, 127316816
, 127316817
, 127316818
, 135651514
, 137006567
, 138355247
, 164228112
, 164761568
, 178102487
, 179293257
, 198951720
, 198991667
, 236466655
, 250135039
, 252455510
, 252467954
|
|||||
| ChEBI ID |
CHEBI:15650
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | MRP1 | Transporter Info | Multidrug resistance-associated protein 1 | Substrate | [2] | |
| OATP1B1 | Transporter Info | Organic anion transporting polypeptide 1B1 | Substrate | [3] | ||
| References | ||||||
| 1 | ClinicalTrials.gov (NCT01841164) A Mechanistic Study to Evaluate the Efficacy of Montelukast on Airway Function in Asthma | |||||
| 2 | Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res. 1996 Mar 1;56(5):988-94. | |||||
| 3 | Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake. Pharmacol Rev. 2011 Mar;63(1):157-81. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.